CN Patent
CN100574761C — 吗替麦考酚酯干混悬剂
Assigned to Sinopharm Chuankang Pharmaceutical Co Ltd · Expires 2009-12-30 · 16y expired
What this patent protects
本发明公开了一种吗替麦考酚酯干混悬剂。它包含如下组分和含量(重量份):吗替麦考酚酯125~600份、填充剂400~1000份、甜味剂10~60份、助悬剂50~100份、润湿剂适量。干混悬剂具有服用方便、生产量大、便于质量控制、利于患者服用等优点。
USPTO Abstract
本发明公开了一种吗替麦考酚酯干混悬剂。它包含如下组分和含量(重量份):吗替麦考酚酯125~600份、填充剂400~1000份、甜味剂10~60份、助悬剂50~100份、润湿剂适量。干混悬剂具有服用方便、生产量大、便于质量控制、利于患者服用等优点。
Drugs covered by this patent
- Cellcept (MYCOPHENOLATE MOFETIL) · Roche Palo
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.